RTC
CERE

Riverview Trust Company’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Riverview Trust Company’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-385
Closed -$15.7K – 859
2024
Q2 		$15.7K Hold
385
– – 0.01% 533
2024
Q1 		$16.3K Buy
+385
New +$16.2K 0.01% 565

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Riverview Trust Company's CERE Position: Q3 2024 in Review

Riverview Trust Company sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 385 shares — an estimated $15.7K sold.

Riverview Trust Company first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $16.3K in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Riverview Trust Company reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Riverview Trust Company sold 385 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $15.7K.
  • Riverview Trust Company first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Riverview Trust Company's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $16.3K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Riverview Trust Company's 13F filing for Q3 2024, filed 18 Oct 2024.